The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
about
Short-term administration of growth hormone (GH) lowers blood pressure by activating eNOS/nitric oxide (NO)-pathway in male hypophysectomized (Hx) rats.The inherited bone marrow failure syndromesL-arginine as a nutritional prophylaxis against vascular endothelial dysfunction with aging.Should we start and continue growth hormone (GH) replacement therapy in adults with GH deficiency?Extracellular water and blood pressure in adults with growth hormone (GH) deficiency: a genotype-phenotype association study.Vasoprotective effects of life span-extending peripubertal GH replacement in Lewis dwarf ratsHypopituitarism and atherosclerosis.Growth hormone deficiency and vascular risk.Cardiovascular effects of growth hormone treatment: potential risks and benefits.Growth hormone and IGF-1 deficiency exacerbate high-fat diet-induced endothelial impairment in obese Lewis dwarf rats: implications for vascular agingThe emerging role of IGF-1 deficiency in cardiovascular aging: recent advancesEndothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice.Arterial pulse wave velocity, inflammatory markers, pathological GH and IGF states, cardiovascular and cerebrovascular disease.Fanconi anemia: a signal transduction and DNA repair pathway.Exercise-Induced Oxidative Stress Responses in the Pediatric PopulationOne-year GH replacement therapy reduces early cardiac target organ damage (TOD) in adult GHD patients.Imbalance in the blood antioxidant system in growth hormone-deficient children before and after 1 year of recombinant growth hormone therapy.Recombinant human growth hormone and insulin-like growth factor-1 do not affect mitochondrial derived highly reactive oxygen species production in peripheral blood mononuclear cells under conditions of substrate saturation in-vitro.Effects of GH on lipid peroxidation and neutrophil superoxide anion-generating capacity in hypopituitary adults with GH deficiency.Plasma homocysteine is not a major risk factor for vascular disease in growth hormone deficient adults.Effects of GH replacement on endothelial function and large-artery stiffness in GH-deficient adults: a randomized, double-blind, placebo-controlled study.Determination of oxidative protein and lipid damage in adult hypopituitary patients with GH deficiency.Growth hormone (GH) treatment does not restore endothelial function in children with GH deficiency.Circulating insulin-like growth factor-I levels are correlated with the atherosclerotic profile in healthy subjects independently of age.Alterations in the oxidant-antioxidant status in prepubertal children with growth hormone deficiency: effect of growth hormone replacement therapy.GH replacement reduces increased lipid peroxidation in GH-deficient adults.Antioxidation improves in puberty in normal weight and obese boys, in positive association with exercise-stimulated growth hormone secretion.Chronic limb-threatening ischemia could benefit from growth hormone therapy for wound healing and limb salvage.Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency.The Role of Midkine in Arteriogenesis, Involving Mechanosensing, Endothelial Cell Proliferation, and Vasodilation
P2860
Q24811861-47EF81DF-C396-4C86-A4CE-FBA74B21244DQ26999046-0C6B82D9-47AF-4FB2-BD32-DDE87C104EEDQ34070390-3D9D14B6-BB00-4D7F-822A-6ABA793A92A5Q34087419-BDE8935F-D523-49F0-AAB1-CF44A839471BQ34090179-774D2A44-2876-49B0-991C-D3CCA0C66779Q34195272-0FD054BB-AAF4-4305-8031-53929DA850DBQ34420018-7E990DED-2F4A-47F3-8454-BEFBFF85EEF5Q34722657-90368060-6DE7-4889-BEF4-63E678AE4305Q35946594-F5C0E0CD-0F56-4A4B-AAD9-F71FD92D8723Q35947412-20DEFE51-ED65-45B5-9927-EC95EB15CE4BQ35947431-660B9C08-5DE4-4519-AA06-1D6682D7E2E0Q37038972-0CDB7CF0-FC4B-4597-BE20-53D32FC921BCQ37145687-A8056672-35FC-47B1-BA3C-B3AF6C72943BQ37358559-DC3FC25B-AA7C-4E47-8815-D67EAB732190Q37741214-0EB6AF6F-6F84-4FFD-AA9B-262B952670E1Q39852966-F9E874FA-B244-4680-A237-31DFBE736D98Q41593617-C148F37B-3A26-4511-817D-964A19160FEDQ42432765-C5629A9F-84FF-4B18-ACBB-DF09BA0597DBQ42520402-CE618738-CC83-450E-ADDC-149C00CC4DB9Q43917955-5C973439-5BC5-4F0F-A6F4-A2267A9AF484Q43967285-88D5B4E2-E0BF-4E55-9FEA-406F2F96C983Q44753276-A5CF278E-99AC-4579-9361-BCCE34081C98Q46537680-E69BB9F1-AADD-41E7-9BDE-7FC51566DE67Q46631268-04D09A53-4B91-453A-99A0-6CE801A2D042Q46789858-239E8374-FBBB-489D-8AF8-41247815437DQ46887509-AA7417EB-EB14-4928-8470-2898983BEFD9Q47389564-28B038B3-9062-4642-AD10-E6AFFBD9DA97Q48358527-932F1622-067D-4862-8767-15578C3037ADQ51197845-DBE1A148-AEB0-4EAA-878C-3C5E4540C42BQ58692821-D216B627-C24E-4474-8EDB-9EB885A1663B
P2860
The effect of GH replacement therapy on endothelial function and oxidative stress in adult growth hormone deficiency.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh
2000年學術文章
@zh-hant
name
The effect of GH replacement t ...... ult growth hormone deficiency.
@en
The effect of GH replacement t ...... ult growth hormone deficiency.
@nl
type
label
The effect of GH replacement t ...... ult growth hormone deficiency.
@en
The effect of GH replacement t ...... ult growth hormone deficiency.
@nl
prefLabel
The effect of GH replacement t ...... ult growth hormone deficiency.
@en
The effect of GH replacement t ...... ult growth hormone deficiency.
@nl
P2093
P356
P1476
The effect of GH replacement t ...... ult growth hormone deficiency.
@en
P2093
J S Davies
M F Scanlon
M P Frenneaux
R A Anderson
S K Jackson
P304
P356
10.1530/EJE.0.1420254
P577
2000-03-01T00:00:00Z